SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-22-006392
Filing Date
2022-08-22
Accepted
2022-08-22 18:29:40
Documents
2
Period of Report
2022-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3403
2 POWER OF ATTORNEY cure_ex24.htm EX-24 8382
  Complete submission text file 0001477932-22-006392.txt   13186
Mailing Address 7633 E. 63RD PLACE, #220 TULSA OK 74133
Business Address
Davidson Robert Steven (Reporting) CIK: 0001412747 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55908 | Film No.: 221184749

Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Issuer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations